Search

Your search keyword '"Turchi, Beatrice"' showing total 100 results

Search Constraints

Start Over You searched for: Author "Turchi, Beatrice" Remove constraint Author: "Turchi, Beatrice"
100 results on '"Turchi, Beatrice"'

Search Results

2. Hypospadias management in children with anorectal malformation: a multidisciplinary single center experience

3. Post-voided residual urine ratio as a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: development of a clinical nomogram

4. The Impact of a Healthy Lifestyle on Lower Urinary Tract Symptoms and Erectile Function: A Prospective Study.

5. Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function.

6. Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database

7. MP60-19 ONCOLOGICAL OUTCOMES OF LOW VOLUME CRPC: RESULTS FROM A LONGITUDINAL REAL-LIFE MULTICENTER COHORT

8. Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate

9. Residents and Consultants Have Equal Outcomes When Performing Transrectal Fusion Biopsies: A Randomized Clinical Trial

11. Quality of information and appropriateness of Open AI outputs for prostate cancer

22. Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter Cohort

23. 85 - Major Adverse Cardiovascular Events (MACE) related to phosphodiesterase 5 inhibitors (PDE5I): Analysis of real-life data from Eudra-Vigilance (EV) database

24. 76 - Do serum inflammatory indexes predict prostatic inflammation after prostate surgery?

26. MP63-12 THE EFFECTS OF SEQUENTIAL MITOMYCIN AND BACILLUS CALMETTE-GUÉRIN TREATMENT VERSUS BACILLUS CALMETTE-GUÉRIN MONOTHERAPY IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER: MITO-BCG (EUDRACT-2017-004540-37)

27. MP34-14 MEDICATIONS MOSTLY ASSOCIATED WITH URINARY TRACT INFECTIONS (UTIS): ASSESSMENT OF THE EUDRAVIGILANCE (EV) AND FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASES ENTRIES

28. MP24-13 PROSTATE SHAPE AND INTRAVESICAL PROSTATIC PROTRUSION ASSESSED BY MAGNETIC RESONANCE IMAGING ARE RELATED TO URINARY SYMPTOMS

29. Letter to the Editor: How Useful are Current Chatbots Regarding Urology Patient Information? Comparison of the Ten Most Popular Chatbots' Responses About Female Urinary Incontinence.

30. Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review

31. Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the Eudra-Vigilance Database

32. Post-voided residual urine ratio as a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: development of a clinical nomogram

34. 45 - Post-voided residual urine ratio is a predictor of detrusor underactivity in men with lower urinary tract symptoms: Development of a clinical nomogram

36. 46 - Medications mostly associated with urinary retention: Assessment of the EudraVigilance (EV) and the Food and Drug Administration (FDA) pharmacovigilance database entries

37. 38 - Prostate shape and intravesical prostatic protrusion assessed by magnetic resonance imaging are related to urinary symptoms

38. 39 - Medications mostly associated with urinary tract infections (UTIs): Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) pharmacovigilance databases entries

39. 37 - Assessment of Bladder Wall Thickness (DWT) on multiparametric MRI depends on bladder volume

40. 36 - Sexual and functional outcomes after trans-urethral incision of the prostate: A long term follow up analysis

41. 35 - Post-voided residual urine ratio is a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: Development of a clinical nomogram

42. PD45-12 SEXUAL AND FUNCTIONAL OUTCOMES AFTER TRANS-URETHRAL INCISION OF THE PROSTATE: A LONG TERM FOLLOW UP ANALYSIS

43. MP07-13 MEDICATIONS MOSTLY ASSOCIATED WITH HAEMATURIA: ASSESSMENT OF THE EUDRAVIGILANCE (EV) AND FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASES ENTRIES

44. PD39-03 POST-VOIDED RESIDUAL URINE RATIO IS A PREDICTOR OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS: DEVELOPMENT OF A CLINICAL NOMOGRAM

45. PD38-03 ROLE OF POST-VOIDED RESIDUAL RATIO IN PATIENTS WITH DETRUSOR UNDERACTIVITY: A PRESSURE-FLOW STUDY ANALYSIS

46. MP48-11 CARDIOVASCULAR ADVERSE EVENTS-RELATED TO GNRH AGONISTS AND GNRH ANTAGONISTS: ANALYSIS OF REAL-LIFE DATA FROM EUDRA-VIGILANCE DATABASE

47. MP58-01 IS MRI AND FUSION BIOPSIES NECESSARY IN PATIENTS WITH PSA LEVELS >10 NG/ML?

48. MP19-09 OPEN ACCESS JOURNALS HAVE HIGHER METRICS THAN NON-OPEN ACCESS JOURNALS: ANALYSIS OF EUROPEAN UROLOGY AND JOURNAL OF UROLOGY METRICS

49. MP48-06 ADVERSE EVENTS RELATED TO DAROLUTAMIDE TREATMENT: ANALYSIS OF “REAL LIFE” DATA FROM EUDRAVIGILANCE (EV) AND THE FOOD AND DRUG ADMINISTRATION (FDA) DATABASE ENTRIES

Catalog

Books, media, physical & digital resources